2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 396.31

-0.6%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: arun gera who wrote (156007)	4/5/2020 11:49:17 PM
From: Dr. Voodoo	2 Recommendations Recommended By elmatador marcher Read Replies (1) of 218913

Drug resistant bacteria are still largely a hospital acquired problem, and with good practice almost never seems to get very far. I used to work on drug resistant infectious many years ago, and have listened to all the public health sky screamers about selling antibiotics on the street corner. Western monopoly on this is very very overrated and would probably do doctors and pharma a service by opening up that shop in the west. That said, i'm adamantly opposed to things with a narrow therapeutic window and limited use being available on amazon, addictive stuff etc... Its all kind of about the volume and the consequence of it. I don't really know why I believe this aside from China, Mexico, Thailand, India...etc. Real world it just never seems to pass the sniff test. Not to say that we won't get a multi-drug resistant bacterium some day that's as bad as COVID, but i would be more concerned about another virus jumping host than I would about bacterial resistance in wide populations.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next